Nage Stock Analysis Niagen Bioscience Inc. Falls 3.10 To 4.38 Amid Biotech Market Shifts 20260403 KLAR Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response ATAT Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat HYPD Q1 2026 Earnings Significant EPS Miss Sends Shares Lower MRSH Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations RMBS Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Revenue Discrepancy LightPath Technologies Q1 2026 Earnings EPS Misses Estimates Yet Stock Surges 187